Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling.
Saved in:
| Title: | Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling. |
|---|---|
| Authors: | Norita R; Department of Vascular Biology, Institute of Development Aging, and Cancer, Tohoku University, Sendai, Japan., Suzuki Y; Department of Vascular Biology, Institute of Development Aging, and Cancer, Tohoku University, Sendai, Japan., Furutani Y; Micro-Signaling Regulation Technology Unit, RIKEN Center for Life Science Technologies, Saitama, Japan., Takahashi K; Laboratory of Oncology, Graduate School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan., Yoshimatsu Y; Department of Cellular Physiological Chemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan., Podyma-Inoue KA; Department of Biochemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan., Watabe T; Department of Biochemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan., Sato Y; Department of Vascular Biology, Institute of Development Aging, and Cancer, Tohoku University, Sendai, Japan. |
| Source: | Cancer science [Cancer Sci] 2017 Mar; Vol. 108 (3), pp. 419-426. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print Cited Medium: Internet ISSN: 1349-7006 (Electronic) Linking ISSN: 13479032 NLM ISO Abbreviation: Cancer Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 28064471 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Norita+R%22">Norita R</searchLink>; Department of Vascular Biology, Institute of Development Aging, and Cancer, Tohoku University, Sendai, Japan.<br /><searchLink fieldCode="AU" term="%22Suzuki+Y%22">Suzuki Y</searchLink>; Department of Vascular Biology, Institute of Development Aging, and Cancer, Tohoku University, Sendai, Japan.<br /><searchLink fieldCode="AU" term="%22Furutani+Y%22">Furutani Y</searchLink>; Micro-Signaling Regulation Technology Unit, RIKEN Center for Life Science Technologies, Saitama, Japan.<br /><searchLink fieldCode="AU" term="%22Takahashi+K%22">Takahashi K</searchLink>; Laboratory of Oncology, Graduate School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Yoshimatsu+Y%22">Yoshimatsu Y</searchLink>; Department of Cellular Physiological Chemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Podyma-Inoue+KA%22">Podyma-Inoue KA</searchLink>; Department of Biochemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Watabe+T%22">Watabe T</searchLink>; Department of Biochemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Sato+Y%22">Sato Y</searchLink>; Department of Vascular Biology, Institute of Development Aging, and Cancer, Tohoku University, Sendai, Japan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101168776%22">Cancer science</searchLink> [Cancer Sci] 2017 Mar; Vol. 108 (3), pp. 419-426. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley+Publishing+on+behalf+of+the+Japanese+Cancer+Association%22">Wiley Publishing on behalf of the Japanese Cancer Association </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101168776 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1349-7006 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213479032%22">13479032 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Sci <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=28064471 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/cas.13157 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 419 Titles: – TitleFull: Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Norita R – PersonEntity: Name: NameFull: Suzuki Y – PersonEntity: Name: NameFull: Furutani Y – PersonEntity: Name: NameFull: Takahashi K – PersonEntity: Name: NameFull: Yoshimatsu Y – PersonEntity: Name: NameFull: Podyma-Inoue KA – PersonEntity: Name: NameFull: Watabe T – PersonEntity: Name: NameFull: Sato Y IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2017 Mar Type: published Y: 2017 Identifiers: – Type: issn-electronic Value: 1349-7006 Numbering: – Type: volume Value: 108 – Type: issue Value: 3 Titles: – TitleFull: Cancer science Type: main |
| ResultId | 1 |
